Jennie Ann Hutton

Title: Jennie Ann Hutton: Innovator in Medicinal Chemistry

Introduction

Jennie Ann Hutton is a distinguished inventor based in London, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit N-myristoyl transferase. Her work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Jennie Ann Hutton holds 2 patents. Her latest patents focus on compounds and their use as inhibitors of N-myristoyl transferase (NMT). These inventions provide compounds of formula (I) and salts thereof, which exhibit activity as inhibitors of NMT. The applications of these compounds as medicaments are particularly noteworthy, as they can be used in the treatment of diseases such as protozoan infections, viral infections, and hyperproliferative disorders.

Career Highlights

Hutton is associated with Imperial College Innovations Limited, where she continues to advance her research and development efforts. Her innovative work in the field of medicinal chemistry has garnered attention and recognition within the scientific community.

Collaborations

Some of her notable coworkers include Andrew Simon Bell and Edward William Tate. Their collaborative efforts contribute to the advancement of research in medicinal chemistry and related fields.

Conclusion

Jennie Ann Hutton is a prominent figure in the realm of medicinal chemistry, with her inventions paving the way for new therapeutic options. Her dedication to innovation and collaboration highlights the importance of research in addressing complex health challenges.